1. Vigano, P., M. Candiani, A. Monno, E. Giacomini, P. Vercellini, and E. Somigliana, Time to redefine endometriosis including its pro-fibrotic nature. Hum Reprod, 2018. 33(3): p. 347-352.
2. Sampson, J.A., Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation. Am J Pathol, 1927. 3(2): p. 93-110 43.
3. Harada, T., F. Taniguchi, K. Onishi, Y. Kurozawa, K. Hayashi, T. Harada, E. Japan, and G. Children's Study, Obstetrical Complications in Women with Endometriosis: A Cohort Study in Japan. PLoS One, 2016. 11(12): p. e0168476.
4. Hamdan, M., G. Dunselman, T.C. Li, and Y. Cheong, The impact of endometrioma on IVF/ICSI outcomes: a systematic review and meta-analysis. Hum Reprod Update, 2015. 21(6): p. 809-25.
5. Hamdan, M., S.Z. Omar, G. Dunselman, and Y. Cheong, Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis. Obstet Gynecol, 2015. 125(1): p. 79-88.
6. Heidemann, L.N., D. Hartwell, C.H. Heidemann, and K.M. Jochumsen, The relation between endometriosis and ovarian cancer - a review. Acta Obstet Gynecol Scand, 2014. 93(1): p. 20-31.
7. Koga, K., Y. Takemura, Y. Osuga, O. Yoshino, Y. Hirota, T. Hirata, C. Morimoto, M. Harada, T. Yano, and Y. Taketani, Recurrence of ovarian endometrioma after laparoscopic excision. Hum Reprod, 2006. 21(8): p. 2171-4.
8. Perlman, S. and J.J. Kjer, Ovarian damage due to cyst removal: a comparison of endometriomas and dermoid cysts. Acta Obstet Gynecol Scand, 2016. 95(3): p. 285- 90.
9. Gizzo, S., A. Vitagliano, M. Noventa, P. Litta, C. Saccardi, and M. Quaranta, Surgery, endometriosis-related infertility and negative impact on ovarian reserve: "which came first, the hen or the egg?" An unresolved dilemma. Arch Gynecol Obstet, 2015. 292(4): p. 709-11.
10. Muzii, L., A.A. Luciano, E. Zupi, and P.B. Panici, Effect of surgery for endometrioma on ovarian function: a different point of view. J Minim Invasive Gynecol, 2014. 21(4): p. 531-3.
11. Somigliana, E., P. Vercellini, R. Daguati, E. Giambattista, L. Benaglia, and L. Fedele, Effect of delaying post-operative conception after conservative surgery for endometriosis. Reprod Biomed Online, 2010. 20(3): p. 410-5.
12. Somigliana, E., L. Benaglia, A. Paffoni, A. Busnelli, P. Vigano, and P. Vercellini, Risks of conservative management in women with ovarian endometriomas undergoing IVF. Hum Reprod Update, 2015. 21(4): p. 486-99.
13. Tai, F.W., C.Y. Chang, J.H. Chiang, W.C. Lin, and L. Wan, Association of Pelvic Inflammatory Disease with Risk of Endometriosis: A Nationwide Cohort Study Involving 141,460 Individuals. J Clin Med, 2018. 7(11).
14. Kelsey, T.W., R.A. Anderson, P. Wright, S.M. Nelson, and W.H. Wallace, Data-driven assessment of the human ovarian reserve. Mol Hum Reprod, 2012. 18(2): p. 79-87.
15. Kerr, J.B., M. Myers, and R.A. Anderson, The dynamics of the primordial follicle reserve. Reproduction, 2013. 146(6): p. R205-15.
16. Hsueh, A.J., K. Kawamura, Y. Cheng, and B.C. Fauser, Intraovarian control of early folliculogenesis. Endocr Rev, 2015. 36(1): p. 1-24.
17. Shah, J.S., R. Sabouni, K.C. Cayton Vaught, C.M. Owen, D.F. Albertini, and J.H. Segars, Biomechanics and mechanical signaling in the ovary: a systematic review. J Assist Reprod Genet, 2018. 35(7): p. 1135-1148.
18. Zhang, H. and K. Liu, Cellular and molecular regulation of the activation of mammalian primordial follicles: somatic cells initiate follicle activation in adulthood. Hum Reprod Update, 2015. 21(6): p. 779-86.
19. Kawamura, K., N. Kawamura, and A.J. Hsueh, Activation of dormant follicles: a new treatment for premature ovarian failure? Curr Opin Obstet Gynecol, 2016. 28(3): p. 217-22.
20. Grosbois, J. and I. Demeestere, Dynamics of PI3K and Hippo signaling pathways during in vitro human follicle activation. Hum Reprod, 2018. 33(9): p. 1705-1714.
21. Castrillon, D.H., L. Miao, R. Kollipara, J.W. Horner, and R.A. DePinho, Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science, 2003. 301(5630): p. 215-8.
22. Liu, L., S. Rajareddy, P. Reddy, C. Du, K. Jagarlamudi, Y. Shen, D. Gunnarsson, G. Selstam, K. Boman, and K. Liu, Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development, 2007. 134(1): p. 199-209.
23. Pelosi, E., S. Omari, M. Michel, J. Ding, T. Amano, A. Forabosco, D. Schlessinger, and C. Ottolenghi, Constitutively active Foxo3 in oocytes preserves ovarian reserve in mice. Nat Commun, 2013. 4: p. 1843.
24. Li, J., K. Kawamura, Y. Cheng, S. Liu, C. Klein, S. Liu, E.K. Duan, and A.J. Hsueh, Activation of dormant ovarian follicles to generate mature eggs. Proc Natl Acad Sci U S A, 2010. 107(22): p. 10280-4.
25. Reddy, P., L. Liu, D. Adhikari, K. Jagarlamudi, S. Rajareddy, Y. Shen, C. Du, W. Tang, T. Hamalainen, S.L. Peng, Z.J. Lan, A.J. Cooney, I. Huhtaniemi, and K. Liu, Oocyte- specific deletion of Pten causes premature activation of the primordial follicle pool. Science, 2008. 319(5863): p. 611-3.
26. David, A., A. Van Langendonckt, S. Gilliaux, M.M. Dolmans, J. Donnez, and C.A. Amorim, Effect of cryopreservation and transplantation on the expression of kit ligand and anti-Mullerian hormone in human ovarian tissue. Hum Reprod, 2012. 27(4): p. 1088-95.
27. Zondervan, K.T., C.M. Becker, K. Koga, S.A. Missmer, R.N. Taylor, and P. Vigano, Endometriosis. Nat Rev Dis Primers, 2018. 4(1): p. 9.
28. Kitajima, M., K.N. Khan, A. Harada, K. Taniguchi, T. Inoue, M. Kaneuchi, K. Miura, and H. Masuzaki, Association between ovarian endometrioma and ovarian reserve. Front Biosci (Elite Ed), 2018. 10: p. 92-102.
29. Muzii, L., C. Di Tucci, M. Di Feliciantonio, G. Galati, V. Di Donato, A. Musella, I. Palaia, and P.B. Panici, Antimullerian hormone is reduced in the presence of ovarian endometriomas: a systematic review and meta-analysis. Fertil Steril, 2018. 110(5): p. 932-940 e1.
30. Kasapoglu, I., B. Ata, O. Uyaniklar, A. Seyhan, A. Orhan, S. Yildiz Oguz, and G. Uncu, Endometrioma-related reduction in ovarian reserve (ERROR): a prospective longitudinal study. Fertil Steril, 2018. 110(1): p. 122-127.
31. Kitajima, M., S. Defrere, M.M. Dolmans, S. Colette, J. Squifflet, A. Van Langendonckt, and J. Donnez, Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis. Fertil Steril, 2011. 96(3): p. 685-91.
32. Kitajima, M., M.M. Dolmans, O. Donnez, H. Masuzaki, M. Soares, and J. Donnez, Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril, 2014. 101(4): p. 1031-7.
33. Kalich-Philosoph, L., H. Roness, A. Carmely, M. Fishel-Bartal, H. Ligumsky, S. Paglin, I. Wolf, H. Kanety, B. Sredni, and D. Meirow, Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility. Sci Transl Med, 2013. 5(185): p. 185ra62.
34. Kalechman, Y., M. Albeck, M. Oron, D. Sobelman, M. Gurwith, G. Horwith, T. Kirsch, B. Maida, S.N. Sehgal, and B. Sredni, Protective and restorative role of AS101 in combination with chemotherapy. Cancer Res, 1991. 51(5): p. 1499-503.
35. Brodsky, M., S. Yosef, R. Galit, M. Albeck, D.L. Longo, A. Albeck, and B. Sredni, The synthetic tellurium compound, AS101, is a novel inhibitor of IL-1beta converting enzyme. J Interferon Cytokine Res, 2007. 27(6): p. 453-62.
36. Brodsky, M., S. Hirsh, M. Albeck, and B. Sredni, Resolution of inflammation-related apoptotic processes by the synthetic tellurium compound, AS101 following liver injury. J Hepatol, 2009. 51(3): p. 491-503.
37. Brodsky, M., G. Halpert, M. Albeck, and B. Sredni, The anti-inflammatory effects of the tellurium redox modulating compound, AS101, are associated with regulation of NFkappaB signaling pathway and nitric oxide induction in macrophages. J Inflamm (Lond), 2010. 7(1): p. 3.
38. Ling, D., B. Liu, S. Jawad, I.A. Thompson, C.N. Nagineni, J. Dailey, J. Chien, B. Sredni, and R.B. Nussenblatt, The tellurium redox immunomodulating compound AS101 inhibits IL-1beta-activated inflammation in the human retinal pigment epithelium. Br J Ophthalmol, 2013. 97(7): p. 934-8.
39. Indenbaum, V., H. Bin, D. Makarovsky, M. Weil, L.M. Shulman, M. Albeck, B. Sredni, and E. Mendelson, In vitro and in vivo activity of AS101 against West Nile virus (WNV). Virus Res, 2012. 166(1-2): p. 68-76.
40. Sredni, B., M. Albeck, T. Tichler, A. Shani, J. Shapira, I. Bruderman, R. Catane, B. Kaufman, and Y. Kalechman, Bone marrow-sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide. J Clin Oncol, 1995. 13(9): p. 2342-53.
41. Halpert, G. and B. Sredni, The effect of the novel tellurium compound AS101 on autoimmune diseases. Autoimmun Rev, 2014. 13(12): p. 1230-5.
42. Vishwakarma, P., N. Parmar, P. Chandrakar, T. Sharma, M. Kathuria, P.K. Agnihotri, M.I. Siddiqi, K. Mitra, and S. Kar, Ammonium trichloro [1,2-ethanediolato-O,O']- tellurate cures experimental visceral leishmaniasis by redox modulation of Leishmania donovani trypanothione reductase and inhibiting host integrin linked PI3K/Akt pathway. Cell Mol Life Sci, 2018. 75(3): p. 563-588.
43. Takamura, M., K. Koga, G. Izumi, Y. Urata, M. Nagai, A. Hasegawa, M. Harada, T. Hirata, Y. Hirota, O. Wada-Hiraike, T. Fujii, and Y. Osuga, Neutrophil depletion reduces endometriotic lesion formation in mice. Am J Reprod Immunol, 2016. 76(3): p. 193-8.
44. Tomio, K., K. Kawana, A. Taguchi, Y. Isobe, R. Iwamoto, A. Yamashita, S. Kojima, M. Mori, T. Nagamatsu, T. Arimoto, K. Oda, Y. Osuga, Y. Taketani, J.X. Kang, H. Arai, M. Arita, S. Kozuma, and T. Fujii, Omega-3 polyunsaturated Fatty acids suppress the cystic lesion formation of peritoneal endometriosis in transgenic mouse models. PLoS One, 2013. 8(9): p. e73085.
45. Myers, M., K.L. Britt, N.G. Wreford, F.J. Ebling, and J.B. Kerr, Methods for quantifying follicular numbers within the mouse ovary. Reproduction, 2004. 127(5): p. 569-80.
46. Sutherland, J.M., E.R. Frost, E.A. Ford, A.E. Peters, N.L. Reed, A.N. Seldon, B.P. Mihalas, D.L. Russel, K.R. Dunning, and E.A. McLaughlin, Janus kinase JAK1 maintains the ovarian reserve of primordial follicles in the mouse ovary. Mol Hum Reprod, 2018. 24(11): p. 533-542.
47. Gonzalez-Fernandez, R., O. Pena, J. Hernandez, P. Martin-Vasallo, A. Palumbo, and J. Avila, Patients with endometriosis and patients with poor ovarian reserve have abnormal follicle-stimulating hormone receptor signaling pathways. Fertil Steril, 2011. 95(7): p. 2373-8.
48. Sonigo, C., I. Beau, M. Grynberg, and N. Binart, AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice. FASEB J, 2019. 33(1): p. 1278-1287.
49. Jang, H., O.H. Lee, Y. Lee, H. Yoon, E.M. Chang, M. Park, J.W. Lee, K. Hong, J.O. Kim, N.K. Kim, J.J. Ko, D.R. Lee, T.K. Yoon, W.S. Lee, and Y. Choi, Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN/AKT/FOXO3a pathway activation in the mouse ovary. J Pineal Res, 2016. 60(3): p. 336-47.
50. Goldman, K.N., D. Chenette, R. Arju, F.E. Duncan, D.L. Keefe, J.A. Grifo, and R.J. Schneider, mTORC1/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy. Proc Natl Acad Sci U S A, 2017. 114(12): p. 3186-3191.